Edesa Biotech Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
/ 
Frequently asked questions
To buy Edesa Biotech Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Edesa Biotech Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Edesa Biotech Inc. is EDSA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Edesa Biotech Inc. has its primary listing on NASDAQ (Small cap). You can trade Edesa Biotech Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Edesa Biotech Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Edesa Biotech Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Edesa Biotech Inc..